Researcher profile · Semantic Scholar

A. Cataldo

h-index: 12
Works: 25
Citations: 653

Most-cited papers

Exosome-mediated delivery of miR-9 induces cancer-associated fibroblast-like properties in human breast fibroblasts
S. Baroni, S. Romero-Cordoba, I. Plantamura, M. Dugo +7 more
2016Cell Death and Disease280 citations Open access
Semantic Scholar
miR-302b enhances breast cancer cell sensitivity to cisplatin by regulating E2F1 and the cellular DNA damage response
A. Cataldo, Douglas G. Cheung, A. Balsari, E. Tagliabue +4 more
2015OncoTarget74 citations Open access
Semantic Scholar
miR-205 in Breast Cancer: State of the Art
I. Plantamura, A. Cataldo, G. Cosentino, M. Iorio
2020International Journal of Molecular Sciences50 citations Open access
Semantic Scholar
Breast Cancer Drug Resistance: Overcoming the Challenge by Capitalizing on MicroRNA and Tumor Microenvironment Interplay
G. Cosentino, I. Plantamura, E. Tagliabue, M. Iorio +1 more
2021Cancers43 citations Open access
Semantic Scholar
MicroRNA and Oxidative Stress Interplay in the Context of Breast Cancer Pathogenesis
G. Cosentino, I. Plantamura, A. Cataldo, M. Iorio
2019International Journal of Molecular Sciences38 citations Open access
Semantic Scholar
Increased Sensitivity to Chemotherapy Induced by CpG-ODN Treatment Is Mediated by microRNA Modulation
L. De Cecco, Martina Berardi, M. Sommariva, A. Cataldo +5 more
2013PLoS ONE24 citations Open access
Semantic Scholar
The Role of MicroRNAs in HER2-Positive Breast Cancer: Where We Are and Future Prospective
Valentina Fogazzi, Marcel Kapahnke, A. Cataldo, I. Plantamura +4 more
2022Cancers23 citations Open access
Semantic Scholar
miR-9-Mediated Inhibition of EFEMP1 Contributes to the Acquisition of Pro-Tumoral Properties in Normal Fibroblasts
G. Cosentino, S. Romero-Cordoba, I. Plantamura, A. Cataldo +1 more
2020Cells21 citations Open access
Semantic Scholar
High efficacy of CpG-ODN, Cetuximab and Cisplatin combination for very advanced ovarian xenograft tumors
M. Sommariva, M. de Cesare, A. Meini, A. Cataldo +3 more
2013Journal of Translational Medicine20 citations Open access
Semantic Scholar
MiR-205 as predictive biomarker and adjuvant therapeutic tool in combination with trastuzumab
A. Cataldo, C. Piovan, I. Plantamura, E. D'Ippolito +8 more
2018OncoTarget18 citations Open access
Semantic Scholar
MicroRNAs and DNA-Damaging Drugs in Breast Cancer: Strength in Numbers
I. Plantamura, G. Cosentino, A. Cataldo
2018Frontiers in Oncology17 citations Open access
Semantic Scholar
MiR-302b as a Combinatorial Therapeutic Approach to Improve Cisplatin Chemotherapy Efficacy in Human Triple-Negative Breast Cancer
A. Cataldo, S. Romero-Cordoba, I. Plantamura, G. Cosentino +3 more
2020Cancers16 citations Open access
Semantic Scholar
MicroRNA co-expression patterns unravel the relevance of extra cellular matrix and immunity in breast cancer.
M. Dugo, Xiao-Yan Huang, M. Iorio, A. Cataldo +4 more
2018Breast10 citations
Semantic Scholar
Macrophages Impair TLR9 Agonist Antitumor Activity through Interacting with the Anti-PD-1 Antibody Fc Domain
Simone Camelliti, V. Le Noci, F. Bianchi, Chiara Storti +11 more
2021Cancers8 citations Open access
Semantic Scholar
What if the future of HER2‐positive breast cancer patients was written in miRNAs? An exploratory analysis from NeoALTTO study
S. Pizzamiglio, G. Cosentino, C. M. Ciniselli, L. De Cecco +16 more
2021Cancer Medicine8 citations Open access
Semantic Scholar
Genetic Loss of miR-205 Causes Increased Mammary Gland Development
A. Cataldo, Douglas G. Cheung, John P. Hagan, M. Fassan +4 more
2023Non-Coding RNA3 citations Open access
Semantic Scholar
Kaposiform Hemangioendothelioma of the middle ear in a pediatric patient: Outcomes following dual therapy with Sirolimus and Vincristine
A. Cataldo, Marrigje A. de Jong, M. Gross
2020International Journal of Pediatric Otorhinolaryngology Case Reports1 citations
Semantic Scholar
Abstract 1229: miRNA and response to trastuzumab
G. Cosentino, S. Pizzamiglio, C. M. Ciniselli, L. De Cecco +16 more
2022Cancer Research0 citations
Semantic Scholar
Abstract P5-13-26: The future of HER2-positive breast cancer patients might be written in miRNAs: An exploratory analysis from the NeoALTTO study
M. Iorio, S. Pizzamiglio, G. Cosentino, C. M. Ciniselli +16 more
2022Cancer Research0 citations
Semantic Scholar
PO-344 miR-302b as adjuvant therapeutic tool to improve chemotherapy efficacy in human triple negative breast cancer
A. Cataldo, I. Plantamura, Sandra Romero-Cordoba, V. Cancila +4 more
2018ESMO Open0 citations Open access
Semantic Scholar
Abstract 5437: miR-302b as adjuvant therapeutic tool to improve chemotherapy efficacy in human triple-negative breast cancer
A. Cataldo, I. Plantamura, E. D'Ippolito, S. Romero-Cordoba +5 more
20170 citations
Semantic Scholar
MiR-302b improves chemotherapy efficacy in human breast cancer and affects tumor microenvironment
A. Cataldo, I. Plantamura, E. D'Ippolito, S. Baroni +2 more
20160 citations
Semantic Scholar
ANTI-TUMOR ACTIVITY OF CPG-ODN IN OVARIAN XENOGRAFT TUMORS
A. Cataldo
20140 citations
Semantic Scholar
High efficacy of CpG-ODN, Cetuximab and Cisplatin combination for very advanced ovarian xenograft tumors
M. Sommariva, M. de Cesare, A. Meini, A. Cataldo +3 more
2013Journal of Translational Medicine0 citations Open access
Semantic Scholar
702 Role of the Transcription Factor Forkhead Box P3 in Breast Cancer and Metastasis
A. Cataldo, V. Uva, T. Triulzi, P. Casalini +3 more
20120 citations Open access
Semantic Scholar

A. Balsari

×6

M. Daidone×5

L. De Cecco×4

T. Triulzi×4